NCT07220174

Brief Summary

This pilot study will evaluate the usability and safety of software GI Genius™ XR in the Apple Vision Pro™ virtual reality headset when used in conjunction with the GI Genius™ system during routine screening and surveillance colonoscopy procedures. GI Genius™ XR enables colonoscopists to view the standard live endoscopic video feed within a virtual reality environment as an alternative to the conventional endoscopy tower display. The system provides a virtual screen that mirrors the tower video output without any image analysis or interpretation, allowing users to adjust screen size and position for optimal visualization and situational awareness.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 23, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

October 31, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

October 23, 2025

Status Verified

October 1, 2025

Enrollment Period

2 months

First QC Date

October 9, 2025

Last Update Submit

October 21, 2025

Conditions

Outcome Measures

Primary Outcomes (7)

  • Adverse events

    Collection and analysis of any adverse event.

    Day 1

  • GI Genius™ XR critical tasks

    Correct execution of critical tasks through a questionnaire

    Day 1

  • Use effects

    Use effects of the virtual reality headset on endoscopists through a questionnaire.

    Day 1

  • Problem resolution process

    Management of non-specific problem resolution through a questionnaire.

    Day 1

  • Time management

    Time to complete key tasks during the procedure.

    During the procedure

  • Interruption management

    Number and severity of interruptions related to headset messages or other user device interactions.

    Day 1

  • User feedback on usability

    Thematic analysis of qualitative feedback on headset integration.

    Day 1

Secondary Outcomes (1)

  • System Usability Score

    Through study completion, an average of 3 months

Study Arms (1)

Endoscopist with software GI Genius™ XR in headset

EXPERIMENTAL
Device: software GI Genius™ XR on headset

Interventions

The screening or surveillance colonoscopy is performed with the endoscopist wearing the headset and using the software GI Genius™ XR.

Endoscopist with software GI Genius™ XR in headset

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female aged ≥ 45 years;
  • Scheduled for routine CRC screening or surveillance colonoscopy;
  • Written informed consent to participate.
  • Male or female board-certified gastroenterologists experienced with CRC screening and surveillance colonoscopy;
  • Written informed consent to participate.

You may not qualify if:

  • Not able to comply with the protocol requirement;
  • Implanted or worn medical device (pacemaker, defibrillator, insulin pump, etc.).
  • Not able to comply with the protocol requirement;
  • Implanted or worn medical device (pacemaker, defibrillator, insulin pump, etc.);
  • Risk of falls;
  • Seizures;
  • Heart disease;
  • Pregnant;
  • Migraines;
  • Eye or vision disorder;
  • Inner ear disorder;
  • Psychological disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60607, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2025

First Posted

October 23, 2025

Study Start

October 31, 2025

Primary Completion

January 1, 2026

Study Completion

April 1, 2026

Last Updated

October 23, 2025

Record last verified: 2025-10

Locations